Bengaluru, India

Amit Kumar Chattopadhyay

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Amit Kumar Chattopadhyay: Innovating in Pharmacology

Introduction

Amit Kumar Chattopadhyay is a distinguished inventor based in Bengaluru, India, known for his significant contributions to the field of pharmacology. With a total of five patents to his name, Amit's work primarily focuses on the development of compounds that target specific receptors related to various diseases.

Latest Patents

Among his notable innovations are the following latest patents:

1. **Phenylpyrrolidinone Formyl Peptide 2 Receptor Agonists** - This patent involves compounds of Formulae (I)-(IX), which are identified as agonists for formyl peptide 2 (FPR2) and formyl peptide 1 (FPR1) receptors. The compounds are developed for potential therapeutic applications in treating atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and other related conditions.

2. **Aryl Heterocyclic Piperidinone Formyl Peptide 2 Receptor and Formyl Peptide 1 Receptor Agonists** - This patent similarly relates to compounds of formula (I) targeting FPR2 and FPR1 receptors with a focus on treatments for atherosclerosis and heart failure, demonstrating the potential impact of these innovations on public health.

Career Highlights

Amit Kumar Chattopadhyay currently contributes his expertise to Bristol-Myers Squibb Company, an organization renowned for its commitment to researching and developing innovative medicines. His work has focused on advancing the understanding and treatment of critical cardiovascular and pulmonary diseases, showcasing his dedication to improving patient outcomes through innovative science.

Collaborations

Throughout his career, Amit has collaborated with notable coworkers such as Pravin Sudhakar Shirude and Nicholas Ronald Wurtz. These collaborations have fostered a synergistic environment that enhances innovation and accelerates the discovery of new therapeutic agents.

Conclusion

Amit Kumar Chattopadhyay stands out as a prominent inventor in the field of pharmacology, with a robust portfolio of patents that promise to advance medical treatments for serious health conditions. His innovative approach, combined with a strong collaborative spirit, continues to contribute significantly to the scientific community and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…